IL296854A - Antigen-encoding cassettes - Google Patents

Info

Publication number

IL296854A

IL296854A IL296854A IL29685422A IL296854A IL 296854 A IL296854 A IL 296854A IL 296854 A IL296854 A IL 296854A IL 29685422 A IL29685422 A IL 29685422A IL 296854 A IL296854 A IL 296854A

Authority

IL

Israel

Prior art keywords

sequence

nucleic acid

antigen

epitope

encoding nucleic

Prior art date

2020-04-21

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000427 antigen Substances 0.000 title claims description 409
• 108091007433 antigens Proteins 0.000 title claims description 408
• 102000036639 antigens Human genes 0.000 title claims description 408
• 150000007523 nucleic acids Chemical group 0.000 claims description 600
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 412
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 383
• 125000003729 nucleotide group Chemical group 0.000 claims description 341
• 239000002773 nucleotide Substances 0.000 claims description 339
• 239000000203 mixture Substances 0.000 claims description 282
• 210000004027 cell Anatomy 0.000 claims description 228
• 239000013598 vector Substances 0.000 claims description 221
• 238000000034 method Methods 0.000 claims description 156
• 108091034057 RNA (poly(A)) Proteins 0.000 claims description 140
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 138
• 230000014509 gene expression Effects 0.000 claims description 116
• 206010028980 Neoplasm Diseases 0.000 claims description 110
• 229960005486 vaccine Drugs 0.000 claims description 108
• 235000001014 amino acid Nutrition 0.000 claims description 104
• 208000015181 infectious disease Diseases 0.000 claims description 93
• 244000052769 pathogen Species 0.000 claims description 82
• 108091054438 MHC class II family Proteins 0.000 claims description 81
• 229920001184 polypeptide Polymers 0.000 claims description 80
• 102000043131 MHC class II family Human genes 0.000 claims description 78
• 150000001413 amino acids Chemical class 0.000 claims description 67
• 150000002632 lipids Chemical class 0.000 claims description 67
• 108091054437 MHC class I family Proteins 0.000 claims description 65
• 208000035473 Communicable disease Diseases 0.000 claims description 64
• 102000043129 MHC class I family Human genes 0.000 claims description 62
• 108090000623 proteins and genes Proteins 0.000 claims description 62
• 239000012634 fragment Substances 0.000 claims description 48
• 241000700605 Viruses Species 0.000 claims description 47
• 230000027455 binding Effects 0.000 claims description 47
• 230000035772 mutation Effects 0.000 claims description 47
• 102000004169 proteins and genes Human genes 0.000 claims description 46
• 235000018102 proteins Nutrition 0.000 claims description 45
• 210000004881 tumor cell Anatomy 0.000 claims description 44
• 108700028369 Alleles Proteins 0.000 claims description 43
• 230000028993 immune response Effects 0.000 claims description 41
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 40
• 230000001717 pathogenic effect Effects 0.000 claims description 36
• 241000282414 Homo sapiens Species 0.000 claims description 34
• 238000012163 sequencing technique Methods 0.000 claims description 34
• 230000004936 stimulating effect Effects 0.000 claims description 34
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 33
• 241000710929 Alphavirus Species 0.000 claims description 33
• 230000004075 alteration Effects 0.000 claims description 31
• 201000011510 cancer Diseases 0.000 claims description 30
• 108020004414 DNA Proteins 0.000 claims description 27
• 239000008194 pharmaceutical composition Substances 0.000 claims description 27
• 241000894006 Bacteria Species 0.000 claims description 26
• 210000001519 tissue Anatomy 0.000 claims description 26
• 241001217856 Chimpanzee adenovirus Species 0.000 claims description 25
• 230000008488 polyadenylation Effects 0.000 claims description 24
• 241000701022 Cytomegalovirus Species 0.000 claims description 22
• 241000233866 Fungi Species 0.000 claims description 22
• 108091027544 Subgenomic mRNA Proteins 0.000 claims description 22
• 230000003321 amplification Effects 0.000 claims description 20
• 201000010099 disease Diseases 0.000 claims description 20
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 20
• 238000003199 nucleic acid amplification method Methods 0.000 claims description 20
• 241000710959 Venezuelan equine encephalitis virus Species 0.000 claims description 19
• 238000000338 in vitro Methods 0.000 claims description 19
• 230000001965 increasing effect Effects 0.000 claims description 19
• 238000013518 transcription Methods 0.000 claims description 19
• 230000035897 transcription Effects 0.000 claims description 19
• 241000725643 Respiratory syncytial virus Species 0.000 claims description 17
• 241000711549 Hepacivirus C Species 0.000 claims description 16
• 241000701806 Human papillomavirus Species 0.000 claims description 16
• 230000037430 deletion Effects 0.000 claims description 16
• 238000012217 deletion Methods 0.000 claims description 16
• 244000045947 parasite Species 0.000 claims description 16
• 239000003981 vehicle Substances 0.000 claims description 16
• 210000004443 dendritic cell Anatomy 0.000 claims description 15
• 238000004519 manufacturing process Methods 0.000 claims description 14
• 241001678559 COVID-19 virus Species 0.000 claims description 13
• 238000006243 chemical reaction Methods 0.000 claims description 13
• 230000001404 mediated effect Effects 0.000 claims description 13
• 230000037452 priming Effects 0.000 claims description 13
• 229960000814 tetanus toxoid Drugs 0.000 claims description 13
• 239000002671 adjuvant Substances 0.000 claims description 12
• 210000000612 antigen-presenting cell Anatomy 0.000 claims description 12
• 239000002105 nanoparticle Substances 0.000 claims description 12
• 230000037433 frameshift Effects 0.000 claims description 11
• 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 11
• 230000001225 therapeutic effect Effects 0.000 claims description 11
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 11
• 241000710942 Ross River virus Species 0.000 claims description 10
• 241000710960 Sindbis virus Species 0.000 claims description 10
• 238000002347 injection Methods 0.000 claims description 10
• 239000007924 injection Substances 0.000 claims description 10
• 238000007481 next generation sequencing Methods 0.000 claims description 10
• 239000013612 plasmid Substances 0.000 claims description 10
• 238000006467 substitution reaction Methods 0.000 claims description 10
• 230000008685 targeting Effects 0.000 claims description 10
• 241001502567 Chikungunya virus Species 0.000 claims description 9
• 102000004127 Cytokines Human genes 0.000 claims description 9
• 108090000695 Cytokines Proteins 0.000 claims description 9
• 206010066919 Epidemic polyarthritis Diseases 0.000 claims description 9
• 241000700721 Hepatitis B virus Species 0.000 claims description 9
• 241000608292 Mayaro virus Species 0.000 claims description 9
• 241000710961 Semliki Forest virus Species 0.000 claims description 9
• 230000001580 bacterial effect Effects 0.000 claims description 9
• 206010022000 influenza Diseases 0.000 claims description 9
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
• 241000178568 Aura virus Species 0.000 claims description 8
• 230000006820 DNA synthesis Effects 0.000 claims description 8
• 241000725619 Dengue virus Species 0.000 claims description 8
• 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 claims description 8
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims description 8
• 241000008910 Severe acute respiratory syndrome-related coronavirus Species 0.000 claims description 8
• 108090000848 Ubiquitin Proteins 0.000 claims description 8
• 102000044159 Ubiquitin Human genes 0.000 claims description 8
• 238000004949 mass spectrometry Methods 0.000 claims description 8
• 201000001441 melanoma Diseases 0.000 claims description 8
• 208000031261 Acute myeloid leukaemia Diseases 0.000 claims description 7
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims description 7
• 208000003950 B-cell lymphoma Diseases 0.000 claims description 7
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims description 7
• 208000003174 Brain Neoplasms Diseases 0.000 claims description 7
• 206010006187 Breast cancer Diseases 0.000 claims description 7
• 208000026310 Breast neoplasm Diseases 0.000 claims description 7
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims description 7
• 206010009944 Colon cancer Diseases 0.000 claims description 7
• 241000231322 Fort Morgan virus Species 0.000 claims description 7
• 208000008839 Kidney Neoplasms Diseases 0.000 claims description 7
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 7
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims description 7
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims description 7
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims description 7
• 206010033128 Ovarian cancer Diseases 0.000 claims description 7
• 206010061535 Ovarian neoplasm Diseases 0.000 claims description 7
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 7
• 206010060862 Prostate cancer Diseases 0.000 claims description 7
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 7
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 claims description 7
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 claims description 7
• 206010038389 Renal cancer Diseases 0.000 claims description 7
• 208000005718 Stomach Neoplasms Diseases 0.000 claims description 7
• 208000024313 Testicular Neoplasms Diseases 0.000 claims description 7
• 206010057644 Testis cancer Diseases 0.000 claims description 7
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims description 7
• 238000003776 cleavage reaction Methods 0.000 claims description 7
• 208000029742 colonic neoplasm Diseases 0.000 claims description 7
• 206010017758 gastric cancer Diseases 0.000 claims description 7
• 201000010536 head and neck cancer Diseases 0.000 claims description 7
• 208000014829 head and neck neoplasm Diseases 0.000 claims description 7
• 201000010982 kidney cancer Diseases 0.000 claims description 7
• 201000005202 lung cancer Diseases 0.000 claims description 7
• 208000020816 lung neoplasm Diseases 0.000 claims description 7
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 7
• 201000002528 pancreatic cancer Diseases 0.000 claims description 7
• 208000008443 pancreatic carcinoma Diseases 0.000 claims description 7
• 230000001124 posttranscriptional effect Effects 0.000 claims description 7
• 238000012545 processing Methods 0.000 claims description 7
• 230000007017 scission Effects 0.000 claims description 7
• 201000011549 stomach cancer Diseases 0.000 claims description 7
• 201000003120 testicular cancer Diseases 0.000 claims description 7
• 238000013519 translation Methods 0.000 claims description 7
• 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 6
• 102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 6
• 108010064171 Lysosome-Associated Membrane Glycoproteins Proteins 0.000 claims description 6
• 102000014944 Lysosome-Associated Membrane Glycoproteins Human genes 0.000 claims description 6
• 108700026244 Open Reading Frames Proteins 0.000 claims description 6
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
• 206010041067 Small cell lung cancer Diseases 0.000 claims description 6
• 208000000389 T-cell leukemia Diseases 0.000 claims description 6
• 239000002253 acid Substances 0.000 claims description 6
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims description 6
• 125000000539 amino acid group Chemical group 0.000 claims description 6
• 231100000221 frame shift mutation induction Toxicity 0.000 claims description 6
• 239000005090 green fluorescent protein Substances 0.000 claims description 6
• 238000001727 in vivo Methods 0.000 claims description 6
• 238000000746 purification Methods 0.000 claims description 6
• 208000000587 small cell lung carcinoma Diseases 0.000 claims description 6
• NRLNQCOGCKAESA-KWXKLSQISA-N [(6z,9z,28z,31z)-heptatriaconta-6,9,28,31-tetraen-19-yl] 4-(dimethylamino)butanoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCC(OC(=O)CCCN(C)C)CCCCCCCC\C=C/C\C=C/CCCCC NRLNQCOGCKAESA-KWXKLSQISA-N 0.000 claims description 5
• 210000004899 c-terminal region Anatomy 0.000 claims description 5
• 230000003053 immunization Effects 0.000 claims description 5
• 238000002649 immunization Methods 0.000 claims description 5
• 238000003780 insertion Methods 0.000 claims description 5
• 230000037431 insertion Effects 0.000 claims description 5
• 230000032258 transport Effects 0.000 claims description 5
• 201000008827 tuberculosis Diseases 0.000 claims description 5
• 108020005345 3' Untranslated Regions Proteins 0.000 claims description 4
• 125000001433 C-terminal amino-acid group Chemical group 0.000 claims description 4
• 101710094648 Coat protein Proteins 0.000 claims description 4
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 4
• 108060001084 Luciferase Proteins 0.000 claims description 4
• 239000005089 Luciferase Substances 0.000 claims description 4
• 235000004279 alanine Nutrition 0.000 claims description 4
• 230000006472 autoimmune response Effects 0.000 claims description 4
• 230000003247 decreasing effect Effects 0.000 claims description 4
• 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims description 4
• 230000001939 inductive effect Effects 0.000 claims description 4
• 108020004999 messenger RNA Proteins 0.000 claims description 4
• 230000008707 rearrangement Effects 0.000 claims description 4
• 230000006798 recombination Effects 0.000 claims description 4
• 238000005215 recombination Methods 0.000 claims description 4
• 230000001105 regulatory effect Effects 0.000 claims description 4
• 108020003589 5' Untranslated Regions Proteins 0.000 claims description 3
• 108060003951 Immunoglobulin Proteins 0.000 claims description 3
• 101710128560 Initiator protein NS1 Proteins 0.000 claims description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 3
• 101710144127 Non-structural protein 1 Proteins 0.000 claims description 3
• 239000002299 complementary DNA Substances 0.000 claims description 3
• 239000003937 drug carrier Substances 0.000 claims description 3
• 102000018358 immunoglobulin Human genes 0.000 claims description 3
• 238000002156 mixing Methods 0.000 claims description 3
• 230000030147 nuclear export Effects 0.000 claims description 3
• 230000002093 peripheral effect Effects 0.000 claims description 3
• 238000002205 phenol-chloroform extraction Methods 0.000 claims description 3
• 239000000377 silicon dioxide Substances 0.000 claims description 3
• 108700026220 vif Genes Proteins 0.000 claims description 3
• OGHAROSJZRTIOK-KQYNXXCUSA-O 7-methylguanosine Chemical compound C1=2N=C(N)NC(=O)C=2[N+](C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OGHAROSJZRTIOK-KQYNXXCUSA-O 0.000 claims description 2
• 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 2
• 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 2
• 206010005003 Bladder cancer Diseases 0.000 claims description 2
• 108091035707 Consensus sequence Proteins 0.000 claims description 2
• HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 claims description 2
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 2
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 2
• 108010065805 Interleukin-12 Proteins 0.000 claims description 2
• 108010002350 Interleukin-2 Proteins 0.000 claims description 2
• 108010002586 Interleukin-7 Proteins 0.000 claims description 2
• 108091092724 Noncoding DNA Proteins 0.000 claims description 2
• 108010029485 Protein Isoforms Proteins 0.000 claims description 2
• 102000001708 Protein Isoforms Human genes 0.000 claims description 2
• 108010076504 Protein Sorting Signals Proteins 0.000 claims description 2
• 101800001758 RNA-directed RNA polymerase nsP4 Proteins 0.000 claims description 2
• 108700008625 Reporter Genes Proteins 0.000 claims description 2
• 108010003723 Single-Domain Antibodies Proteins 0.000 claims description 2
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 2
• 241001492404 Woodchuck hepatitis virus Species 0.000 claims description 2
• 230000004913 activation Effects 0.000 claims description 2
• 208000014619 adult acute lymphoblastic leukemia Diseases 0.000 claims description 2
• 238000013459 approach Methods 0.000 claims description 2
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims description 2
• 210000000234 capsid Anatomy 0.000 claims description 2
• 210000000852 deltoid muscle Anatomy 0.000 claims description 2
• 230000005847 immunogenicity Effects 0.000 claims description 2
• 230000005764 inhibitory process Effects 0.000 claims description 2
• 108010074108 interleukin-21 Proteins 0.000 claims description 2
• 230000002147 killing effect Effects 0.000 claims description 2
• 210000001165 lymph node Anatomy 0.000 claims description 2
• 210000004962 mammalian cell Anatomy 0.000 claims description 2
• 230000036961 partial effect Effects 0.000 claims description 2
• 210000003314 quadriceps muscle Anatomy 0.000 claims description 2
• 238000007920 subcutaneous administration Methods 0.000 claims description 2
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
• 235000002374 tyrosine Nutrition 0.000 claims description 2
• 201000005112 urinary bladder cancer Diseases 0.000 claims description 2
• 241000315672 SARS coronavirus Species 0.000 claims 3
• 108090000172 Interleukin-15 Proteins 0.000 claims 1
• 108010065868 RNA polymerase SP6 Proteins 0.000 claims 1
• 101710137500 T7 RNA polymerase Proteins 0.000 claims 1
• 210000004072 lung Anatomy 0.000 claims 1
• 125000005647 linker group Chemical group 0.000 description 70
• 101000941029 Homo sapiens Endoplasmic reticulum junction formation protein lunapark Proteins 0.000 description 37
• 101000991410 Homo sapiens Nucleolar and spindle-associated protein 1 Proteins 0.000 description 37
• 102100030991 Nucleolar and spindle-associated protein 1 Human genes 0.000 description 37
• 230000005867 T cell response Effects 0.000 description 33
• 210000004988 splenocyte Anatomy 0.000 description 32
• -1 e.g. Proteins 0.000 description 23
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 22
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 21
• 102000039446 nucleic acids Human genes 0.000 description 20
• 108020004707 nucleic acids Proteins 0.000 description 20
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 20
• 230000000638 stimulation Effects 0.000 description 19
• 125000004400 (C1-C12) alkyl group Chemical group 0.000 description 17
• 241001465754 Metazoa Species 0.000 description 17
• 230000002516 postimmunization Effects 0.000 description 17
• 239000000523 sample Substances 0.000 description 17
• 150000001721 carbon Chemical group 0.000 description 16
• 229910052799 carbon Inorganic materials 0.000 description 16
• 230000000890 antigenic effect Effects 0.000 description 15
• 101150106931 IFNG gene Proteins 0.000 description 14
• 210000003719 b-lymphocyte Anatomy 0.000 description 14
• 102000040430 polynucleotide Human genes 0.000 description 14
• 108091033319 polynucleotide Proteins 0.000 description 14
• 239000002157 polynucleotide Substances 0.000 description 14
• 241000725303 Human immunodeficiency virus Species 0.000 description 12
• 230000000295 complement effect Effects 0.000 description 12
• 235000012000 cholesterol Nutrition 0.000 description 11
• 230000002163 immunogen Effects 0.000 description 11
• LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 10
• 241000282412 Homo Species 0.000 description 10
• 239000002202 Polyethylene glycol Substances 0.000 description 10
• 230000036755 cellular response Effects 0.000 description 10
• 229920001223 polyethylene glycol Polymers 0.000 description 10
• 101150079396 trpC2 gene Proteins 0.000 description 10
• 239000011203 carbon fibre reinforced carbon Substances 0.000 description 9
• 230000007935 neutral effect Effects 0.000 description 9
• 150000003904 phospholipids Chemical class 0.000 description 9
• 238000003752 polymerase chain reaction Methods 0.000 description 9
• 238000003786 synthesis reaction Methods 0.000 description 9
• 238000013461 design Methods 0.000 description 8
• 238000005457 optimization Methods 0.000 description 8
• 125000006850 spacer group Chemical group 0.000 description 8
• 241000713311 Simian immunodeficiency virus Species 0.000 description 7
• 108091026890 Coding region Proteins 0.000 description 6
• 108020004705 Codon Proteins 0.000 description 6
• 241000699670 Mus sp. Species 0.000 description 6
• 238000001514 detection method Methods 0.000 description 6
• 239000013604 expression vector Substances 0.000 description 6
• 210000002443 helper t lymphocyte Anatomy 0.000 description 6
• 230000004044 response Effects 0.000 description 6
• 238000012360 testing method Methods 0.000 description 6
• 241000701161 unidentified adenovirus Species 0.000 description 6
• 230000003612 virological effect Effects 0.000 description 6
• 108060002716 Exonuclease Proteins 0.000 description 5
• 241000699666 Mus <mouse, genus> Species 0.000 description 5
• 238000004458 analytical method Methods 0.000 description 5
• 150000001875 compounds Chemical class 0.000 description 5
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 5
• 238000005516 engineering process Methods 0.000 description 5
• 102000013165 exonuclease Human genes 0.000 description 5
• 230000004927 fusion Effects 0.000 description 5
• 230000001737 promoting effect Effects 0.000 description 5
• 210000002966 serum Anatomy 0.000 description 5
• NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 description 4
• 241000711573 Coronaviridae Species 0.000 description 4
• 101800000324 Immunoglobulin A1 protease translocator Proteins 0.000 description 4
• 241000288906 Primates Species 0.000 description 4
• 108010001267 Protein Subunits Proteins 0.000 description 4
• 102000002067 Protein Subunits Human genes 0.000 description 4
• 230000002776 aggregation Effects 0.000 description 4
• 238000004220 aggregation Methods 0.000 description 4
• 230000008901 benefit Effects 0.000 description 4
• 230000000694 effects Effects 0.000 description 4
• 230000036039 immunity Effects 0.000 description 4
• 230000001976 improved effect Effects 0.000 description 4
• 230000004481 post-translational protein modification Effects 0.000 description 4
• 108020001580 protein domains Proteins 0.000 description 4
• 238000002255 vaccination Methods 0.000 description 4
• KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 3
• 206010069754 Acquired gene mutation Diseases 0.000 description 3
• 241000283073 Equus caballus Species 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 3
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 3
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 3
• 108091034117 Oligonucleotide Proteins 0.000 description 3
• 101710149951 Protein Tat Proteins 0.000 description 3
• 125000000217 alkyl group Chemical group 0.000 description 3
• 125000003275 alpha amino acid group Chemical group 0.000 description 3
• 239000013592 cell lysate Substances 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 108020001507 fusion proteins Proteins 0.000 description 3
• 102000037865 fusion proteins Human genes 0.000 description 3
• 230000001900 immune effect Effects 0.000 description 3
• 238000010348 incorporation Methods 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 229910052757 nitrogen Inorganic materials 0.000 description 3
• 125000004433 nitrogen atom Chemical group N* 0.000 description 3
• 239000000047 product Substances 0.000 description 3
• 210000003289 regulatory T cell Anatomy 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 230000037439 somatic mutation Effects 0.000 description 3
• 238000010186 staining Methods 0.000 description 3
• 239000000126 substance Substances 0.000 description 3
• 230000014616 translation Effects 0.000 description 3
• DRHZYJAUECRAJM-DWSYSWFDSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-8a-[(2s,3r,4s,5r,6r)-3-[(2s,3r,4s,5r,6s)-5-[(2s,3r,4s,5r)-4-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-5-[(3s,5s, Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2[C@@]1(C=O)C)O)C(=O)O[C@@H]1O[C@H](C)[C@@H]([C@@H]([C@H]1O[C@H]1[C@@H]([C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@](O)(CO)CO3)O)[C@H](O)CO2)O)[C@H](C)O1)O)O)OC(=O)C[C@@H](O)C[C@H](OC(=O)C[C@@H](O)C[C@@H]([C@@H](C)CC)O[C@H]1[C@@H]([C@@H](O)[C@H](CO)O1)O)[C@@H](C)CC)C(O)=O)[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O DRHZYJAUECRAJM-DWSYSWFDSA-N 0.000 description 2
• 125000002373 5 membered heterocyclic group Chemical group 0.000 description 2
• 125000004070 6 membered heterocyclic group Chemical group 0.000 description 2
• 125000003341 7 membered heterocyclic group Chemical group 0.000 description 2
• 241000272478 Aquila Species 0.000 description 2
• 241000304886 Bacilli Species 0.000 description 2
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 2
• 206010061041 Chlamydial infection Diseases 0.000 description 2
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
• 208000004232 Enteritis Diseases 0.000 description 2
• 241000709661 Enterovirus Species 0.000 description 2
• 241000713800 Feline immunodeficiency virus Species 0.000 description 2
• 241000282324 Felis Species 0.000 description 2
• 241000282326 Felis catus Species 0.000 description 2
• 208000005577 Gastroenteritis Diseases 0.000 description 2
• 206010018693 Granuloma inguinale Diseases 0.000 description 2
• 241000606790 Haemophilus Species 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 108020004485 Nonsense Codon Proteins 0.000 description 2
• 241000713112 Orthobunyavirus Species 0.000 description 2
• 102000035195 Peptidases Human genes 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 241000709664 Picornaviridae Species 0.000 description 2
• 241000233872 Pneumocystis carinii Species 0.000 description 2
• 108010026552 Proteome Proteins 0.000 description 2
• 241000702263 Reovirus sp. Species 0.000 description 2
• 241000607768 Shigella Species 0.000 description 2
• 108091081024 Start codon Proteins 0.000 description 2
• 241000223997 Toxoplasma gondii Species 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• 125000002947 alkylene group Chemical group 0.000 description 2
• 125000000129 anionic group Chemical group 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 210000001124 body fluid Anatomy 0.000 description 2
• 239000006227 byproduct Substances 0.000 description 2
• 125000004432 carbon atom Chemical group C* 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 125000002091 cationic group Chemical group 0.000 description 2
• 238000005119 centrifugation Methods 0.000 description 2
• 108091036078 conserved sequence Proteins 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 206010013023 diphtheria Diseases 0.000 description 2
• 241001493065 dsRNA viruses Species 0.000 description 2
• 206010014599 encephalitis Diseases 0.000 description 2
• 108010078428 env Gene Products Proteins 0.000 description 2
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 2
• 230000006870 function Effects 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 210000004602 germ cell Anatomy 0.000 description 2
• 239000011521 glass Substances 0.000 description 2
• 238000009396 hybridization Methods 0.000 description 2
• 210000002865 immune cell Anatomy 0.000 description 2
• 239000003446 ligand Substances 0.000 description 2
• 201000004792 malaria Diseases 0.000 description 2
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
• 201000009240 nasopharyngitis Diseases 0.000 description 2
• 239000013642 negative control Substances 0.000 description 2
• 238000010647 peptide synthesis reaction Methods 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 102000054765 polymorphisms of proteins Human genes 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 229940002612 prodrug Drugs 0.000 description 2
• 239000000651 prodrug Substances 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 229950010550 resiquimod Drugs 0.000 description 2
• BXNMTOQRYBFHNZ-UHFFFAOYSA-N resiquimod Chemical compound C1=CC=CC2=C(N(C(COCC)=N3)CC(C)(C)O)C3=C(N)N=C21 BXNMTOQRYBFHNZ-UHFFFAOYSA-N 0.000 description 2
• 238000003757 reverse transcription PCR Methods 0.000 description 2
• 239000007790 solid phase Substances 0.000 description 2
• 239000000243 solution Substances 0.000 description 2
• 150000003431 steroids Chemical class 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 230000002194 synthesizing effect Effects 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• 238000011179 visual inspection Methods 0.000 description 2
• 239000001993 wax Substances 0.000 description 2
• FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• KRQUFUKTQHISJB-YYADALCUSA-N 2-[(E)-N-[2-(4-chlorophenoxy)propoxy]-C-propylcarbonimidoyl]-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one Chemical compound CCC\C(=N/OCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1 KRQUFUKTQHISJB-YYADALCUSA-N 0.000 description 1
• LRYZPFWEZHSTHD-HEFFAWAOSA-O 2-[[(e,2s,3r)-2-formamido-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium Chemical class CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](NC=O)COP(O)(=O)OCC[N+](C)(C)C LRYZPFWEZHSTHD-HEFFAWAOSA-O 0.000 description 1
• 108020005176 AU Rich Elements Proteins 0.000 description 1
• 241000606748 Actinobacillus pleuropneumoniae Species 0.000 description 1
• 206010067484 Adverse reaction Diseases 0.000 description 1
• 241000700587 Alphaherpesvirinae Species 0.000 description 1
• 208000004881 Amebiasis Diseases 0.000 description 1
• 206010001980 Amoebiasis Diseases 0.000 description 1
• 241000712891 Arenavirus Species 0.000 description 1
• 241000244186 Ascaris Species 0.000 description 1
• 201000002909 Aspergillosis Diseases 0.000 description 1
• 208000036641 Aspergillus infections Diseases 0.000 description 1
• 241000711404 Avian avulavirus 1 Species 0.000 description 1
• 241000700663 Avipoxvirus Species 0.000 description 1
• 241000193738 Bacillus anthracis Species 0.000 description 1
• 206010044583 Bartonella Infections Diseases 0.000 description 1
• 229920002498 Beta-glucan Polymers 0.000 description 1
• 241000701021 Betaherpesvirinae Species 0.000 description 1
• 241000335423 Blastomyces Species 0.000 description 1
• 206010005098 Blastomycosis Diseases 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 241000588832 Bordetella pertussis Species 0.000 description 1
• 241000589969 Borreliella burgdorferi Species 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 208000003508 Botulism Diseases 0.000 description 1
• 241000712005 Bovine respirovirus 3 Species 0.000 description 1
• 241000589562 Brucella Species 0.000 description 1
• 206010069748 Burkholderia pseudomallei infection Diseases 0.000 description 1
• 208000011691 Burkitt lymphomas Diseases 0.000 description 1
• 208000008889 California Encephalitis Diseases 0.000 description 1
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
• 241000222122 Candida albicans Species 0.000 description 1
• 206010007134 Candida infections Diseases 0.000 description 1
• 241000711506 Canine coronavirus Species 0.000 description 1
• 241000712083 Canine morbillivirus Species 0.000 description 1
• 241000701931 Canine parvovirus Species 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 241000700664 Capripoxvirus Species 0.000 description 1
• 102000005600 Cathepsins Human genes 0.000 description 1
• 108010084457 Cathepsins Proteins 0.000 description 1
• 241000242722 Cestoda Species 0.000 description 1
• 201000009182 Chikungunya Diseases 0.000 description 1
• 241001647372 Chlamydia pneumoniae Species 0.000 description 1
• 241001647378 Chlamydia psittaci Species 0.000 description 1
• 241000606153 Chlamydia trachomatis Species 0.000 description 1
• 206010008631 Cholera Diseases 0.000 description 1
• 206010008803 Chromoblastomycosis Diseases 0.000 description 1
• 208000015116 Chromomycosis Diseases 0.000 description 1
• 241001112696 Clostridia Species 0.000 description 1
• 241000193449 Clostridium tetani Species 0.000 description 1
• 241000223205 Coccidioides immitis Species 0.000 description 1
• 108700010070 Codon Usage Proteins 0.000 description 1
• 208000009802 Colorado tick fever Diseases 0.000 description 1
• 101710139375 Corneodesmosin Proteins 0.000 description 1
• 241000186216 Corynebacterium Species 0.000 description 1
• 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
• 241000709687 Coxsackievirus Species 0.000 description 1
• 201000007336 Cryptococcosis Diseases 0.000 description 1
• 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
• 241000221204 Cryptococcus neoformans Species 0.000 description 1
• 241000223935 Cryptosporidium Species 0.000 description 1
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
• 150000008574 D-amino acids Chemical class 0.000 description 1
• YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 description 1
• 208000001490 Dengue Diseases 0.000 description 1
• 206010012310 Dengue fever Diseases 0.000 description 1
• 241000710829 Dengue virus group Species 0.000 description 1
• 206010012504 Dermatophytosis Diseases 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 description 1
• 208000000655 Distemper Diseases 0.000 description 1
• 208000006825 Eastern Equine Encephalomyelitis Diseases 0.000 description 1
• 201000005804 Eastern equine encephalitis Diseases 0.000 description 1
• 241001115402 Ebolavirus Species 0.000 description 1
• 241001466953 Echovirus Species 0.000 description 1
• 241000588877 Eikenella Species 0.000 description 1
• 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
• 206010014584 Encephalitis california Diseases 0.000 description 1
• 206010014587 Encephalitis eastern equine Diseases 0.000 description 1
• 206010014611 Encephalitis venezuelan equine Diseases 0.000 description 1
• 206010014614 Encephalitis western equine Diseases 0.000 description 1
• 206010053025 Endemic syphilis Diseases 0.000 description 1
• 241000588921 Enterobacteriaceae Species 0.000 description 1
• 241000194032 Enterococcus faecalis Species 0.000 description 1
• 241000991587 Enterovirus C Species 0.000 description 1
• 241000710803 Equine arteritis virus Species 0.000 description 1
• 241000713730 Equine infectious anemia virus Species 0.000 description 1
• 241000186810 Erysipelothrix rhusiopathiae Species 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 108700024394 Exon Proteins 0.000 description 1
• 241000725579 Feline coronavirus Species 0.000 description 1
• 241000711475 Feline infectious peritonitis virus Species 0.000 description 1
• 241000714165 Feline leukemia virus Species 0.000 description 1
• 241000701915 Feline panleukopenia virus Species 0.000 description 1
• 241000701925 Feline parvovirus Species 0.000 description 1
• 201000006353 Filariasis Diseases 0.000 description 1
• 241000711950 Filoviridae Species 0.000 description 1
• 241000710781 Flaviviridae Species 0.000 description 1
• 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
• 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
• 108091006027 G proteins Proteins 0.000 description 1
• 102000030782 GTP binding Human genes 0.000 description 1
• 108091000058 GTP-Binding Proteins 0.000 description 1
• 101710177291 Gag polyprotein Proteins 0.000 description 1
• 241000701047 Gallid alphaherpesvirus 2 Species 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 241000701046 Gammaherpesvirinae Species 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• 241000224466 Giardia Species 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 108060003393 Granulin Proteins 0.000 description 1
• 241000606768 Haemophilus influenzae Species 0.000 description 1
• 206010061192 Haemorrhagic fever Diseases 0.000 description 1
• 241000590002 Helicobacter pylori Species 0.000 description 1
• 208000005176 Hepatitis C Diseases 0.000 description 1
• 241000724709 Hepatitis delta virus Species 0.000 description 1
• 241000709721 Hepatovirus A Species 0.000 description 1
• 208000007514 Herpes zoster Diseases 0.000 description 1
• 241000228402 Histoplasma Species 0.000 description 1
• 201000002563 Histoplasmosis Diseases 0.000 description 1
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 1
• 101001131829 Homo sapiens P protein Proteins 0.000 description 1
• 241001207270 Human enterovirus Species 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• 241000726041 Human respirovirus 1 Species 0.000 description 1
• 241000712003 Human respirovirus 3 Species 0.000 description 1
• 241001559187 Human rubulavirus 2 Species 0.000 description 1
• 241001559186 Human rubulavirus 4 Species 0.000 description 1
• 241000711450 Infectious bronchitis virus Species 0.000 description 1
• 241000702626 Infectious bursal disease virus Species 0.000 description 1
• 102100034353 Integrase Human genes 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 201000005807 Japanese encephalitis Diseases 0.000 description 1
• 241000710843 Japanese encephalitis virus group Species 0.000 description 1
• 201000009908 La Crosse encephalitis Diseases 0.000 description 1
• 206010023927 Lassa fever Diseases 0.000 description 1
• 241000222732 Leishmania major Species 0.000 description 1
• 208000004554 Leishmaniasis Diseases 0.000 description 1
• 241000713666 Lentivirus Species 0.000 description 1
• 241000700563 Leporipoxvirus Species 0.000 description 1
• 206010024229 Leprosy Diseases 0.000 description 1
• 241000589929 Leptospira interrogans Species 0.000 description 1
• 206010024238 Leptospirosis Diseases 0.000 description 1
• 241000186779 Listeria monocytogenes Species 0.000 description 1
• 241000701043 Lymphocryptovirus Species 0.000 description 1
• 241000711828 Lyssavirus Species 0.000 description 1
• 101710125418 Major capsid protein Proteins 0.000 description 1
• 241001293418 Mannheimia haemolytica Species 0.000 description 1
• 241001115401 Marburgvirus Species 0.000 description 1
• 241000283923 Marmota monax Species 0.000 description 1
• 101710085938 Matrix protein Proteins 0.000 description 1
• 108091027974 Mature messenger RNA Proteins 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• 101710127721 Membrane protein Proteins 0.000 description 1
• 101150076359 Mhc gene Proteins 0.000 description 1
• 241001460074 Microsporum distortum Species 0.000 description 1
• 229920006068 Minlon® Polymers 0.000 description 1
• 241000588621 Moraxella Species 0.000 description 1
• 241000588655 Moraxella catarrhalis Species 0.000 description 1
• 241000712045 Morbillivirus Species 0.000 description 1
• 241000711386 Mumps virus Species 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 241000701034 Muromegalovirus Species 0.000 description 1
• 241000041810 Mycetoma Species 0.000 description 1
• 241000186367 Mycobacterium avium Species 0.000 description 1
• 241000186364 Mycobacterium intracellulare Species 0.000 description 1
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
• 241000204031 Mycoplasma Species 0.000 description 1
• 241000204022 Mycoplasma gallisepticum Species 0.000 description 1
• 206010028470 Mycoplasma infections Diseases 0.000 description 1
• 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
• GUVMFDICMFQHSZ-UHFFFAOYSA-N N-(1-aminoethenyl)-1-[4-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[hydroxy-[[3-[hydroxy-[[3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-[[[2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(4-amino-2-oxopyrimidin-1-yl)-2-[[hydroxy-[2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-2-yl]-5-methylimidazole-4-carboxamide Chemical compound CC1=C(C(=O)NC(N)=C)N=CN1C1OC(COP(O)(=S)OC2C(OC(C2)N2C(N=C(N)C=C2)=O)COP(O)(=S)OC2C(OC(C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=S)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=S)OC2C(OC(C2)N2C(N=C(N)C=C2)=O)COP(O)(=S)OC2C(OC(C2)N2C(NC(=O)C(C)=C2)=O)CO)C(OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)O)C1 GUVMFDICMFQHSZ-UHFFFAOYSA-N 0.000 description 1
• 108010084333 N-palmitoyl-S-(2,3-bis(palmitoyloxy)propyl)cysteinyl-seryl-lysyl-lysyl-lysyl-lysine Proteins 0.000 description 1
• 208000006007 Nairobi Sheep Disease Diseases 0.000 description 1
• 241000588653 Neisseria Species 0.000 description 1
• 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
• 241000588650 Neisseria meningitidis Species 0.000 description 1
• 241000244206 Nematoda Species 0.000 description 1
• 206010029443 Nocardia Infections Diseases 0.000 description 1
• 206010029444 Nocardiosis Diseases 0.000 description 1
• 108010066154 Nuclear Export Signals Proteins 0.000 description 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
• 101710141454 Nucleoprotein Proteins 0.000 description 1
• 241000702259 Orbivirus Species 0.000 description 1
• 241000150452 Orthohantavirus Species 0.000 description 1
• 241000150218 Orthonairovirus Species 0.000 description 1
• 241000700629 Orthopoxvirus Species 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 241000700639 Parapoxvirus Species 0.000 description 1
• 208000030852 Parasitic disease Diseases 0.000 description 1
• 241000606856 Pasteurella multocida Species 0.000 description 1
• 241000713137 Phlebovirus Species 0.000 description 1
• 208000004842 Pinta Diseases 0.000 description 1
• 241000711902 Pneumovirus Species 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 241001505332 Polyomavirus sp. Species 0.000 description 1
• 241000156302 Porcine hemagglutinating encephalomyelitis virus Species 0.000 description 1
• 241000702619 Porcine parvovirus Species 0.000 description 1
• 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 101710192141 Protein Nef Proteins 0.000 description 1
• 101710150344 Protein Rev Proteins 0.000 description 1
• 229940096437 Protein S Drugs 0.000 description 1
• 101710149136 Protein Vpr Proteins 0.000 description 1
• 241000588770 Proteus mirabilis Species 0.000 description 1
• 241000588767 Proteus vulgaris Species 0.000 description 1
• 241000125945 Protoparvovirus Species 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 206010037151 Psittacosis Diseases 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 206010037688 Q fever Diseases 0.000 description 1
• 239000013614 RNA sample Substances 0.000 description 1
• 206010037742 Rabies Diseases 0.000 description 1
• 241000701037 Rhadinovirus Species 0.000 description 1
• 206010051497 Rhinotracheitis Diseases 0.000 description 1
• 241000606723 Rickettsia akari Species 0.000 description 1
• 241000606651 Rickettsiales Species 0.000 description 1
• 201000004282 Rickettsialpox Diseases 0.000 description 1
• 208000000705 Rift Valley Fever Diseases 0.000 description 1
• 208000006257 Rinderpest Diseases 0.000 description 1
• 206010039207 Rocky Mountain Spotted Fever Diseases 0.000 description 1
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
• 241000702670 Rotavirus Species 0.000 description 1
• 241000710799 Rubella virus Species 0.000 description 1
• 241000710801 Rubivirus Species 0.000 description 1
• 241001533467 Rubulavirus Species 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 241001138501 Salmonella enterica Species 0.000 description 1
• 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
• 241000242678 Schistosoma Species 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 208000001203 Smallpox Diseases 0.000 description 1
• 101710198474 Spike protein Proteins 0.000 description 1
• 241000605008 Spirillum Species 0.000 description 1
• 206010041736 Sporotrichosis Diseases 0.000 description 1
• 206010041896 St. Louis Encephalitis Diseases 0.000 description 1
• 241000710888 St. Louis encephalitis virus Species 0.000 description 1
• 241000295644 Staphylococcaceae Species 0.000 description 1
• 241000191967 Staphylococcus aureus Species 0.000 description 1
• 229930182558 Sterol Natural products 0.000 description 1
• 241001478880 Streptobacillus moniliformis Species 0.000 description 1
• 241000193985 Streptococcus agalactiae Species 0.000 description 1
• 241000193998 Streptococcus pneumoniae Species 0.000 description 1
• 241000193996 Streptococcus pyogenes Species 0.000 description 1
• 241000700568 Suipoxvirus Species 0.000 description 1
• 208000002847 Surgical Wound Diseases 0.000 description 1
• 108091008874 T cell receptors Proteins 0.000 description 1
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
• 208000026651 T-cell prolymphocytic leukemia Diseases 0.000 description 1
• 206010043376 Tetanus Diseases 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• 208000002474 Tinea Diseases 0.000 description 1
• 241000710924 Togaviridae Species 0.000 description 1
• 201000005485 Toxoplasmosis Diseases 0.000 description 1
• 101800001690 Transmembrane protein gp41 Proteins 0.000 description 1
• 241000242541 Trematoda Species 0.000 description 1
• 241000869417 Trematodes Species 0.000 description 1
• 206010044608 Trichiniasis Diseases 0.000 description 1
• 241000224526 Trichomonas Species 0.000 description 1
• 241001489151 Trichuris Species 0.000 description 1
• 208000034784 Tularaemia Diseases 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 206010046865 Vaccinia virus infection Diseases 0.000 description 1
• 241000701067 Varicellovirus Species 0.000 description 1
• 241000870995 Variola Species 0.000 description 1
• 241000700647 Variola virus Species 0.000 description 1
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
• 208000002687 Venezuelan Equine Encephalomyelitis Diseases 0.000 description 1
• 201000009145 Venezuelan equine encephalitis Diseases 0.000 description 1
• 241000711975 Vesicular stomatitis virus Species 0.000 description 1
• 241000711970 Vesiculovirus Species 0.000 description 1
• 241000607626 Vibrio cholerae Species 0.000 description 1
• 108020000999 Viral RNA Proteins 0.000 description 1
• 101710201961 Virion infectivity factor Proteins 0.000 description 1
• 208000005466 Western Equine Encephalomyelitis Diseases 0.000 description 1
• 201000005806 Western equine encephalitis Diseases 0.000 description 1
• 241000710951 Western equine encephalitis virus Species 0.000 description 1
• 208000003152 Yellow Fever Diseases 0.000 description 1
• 241000120645 Yellow fever virus group Species 0.000 description 1
• 241000607734 Yersinia <bacteria> Species 0.000 description 1
• 206010061418 Zygomycosis Diseases 0.000 description 1
• 241000606834 [Haemophilus] ducreyi Species 0.000 description 1
• 230000001594 aberrant effect Effects 0.000 description 1
• 201000007691 actinomycosis Diseases 0.000 description 1
• 208000012873 acute gastroenteritis Diseases 0.000 description 1
• 230000006838 adverse reaction Effects 0.000 description 1
• 229940037003 alum Drugs 0.000 description 1
• AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• 230000030741 antigen processing and presentation Effects 0.000 description 1
• 238000013528 artificial neural network Methods 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• 201000008680 babesiosis Diseases 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 206010004145 bartonellosis Diseases 0.000 description 1
• 239000003833 bile salt Substances 0.000 description 1
• 229940093761 bile salts Drugs 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 238000001574 biopsy Methods 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 208000003836 bluetongue Diseases 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 238000002619 cancer immunotherapy Methods 0.000 description 1
• 201000003984 candidiasis Diseases 0.000 description 1
• 208000014058 canine distemper Diseases 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000012292 cell migration Effects 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 238000002659 cell therapy Methods 0.000 description 1
• 210000002421 cell wall Anatomy 0.000 description 1
• 108091092328 cellular RNA Proteins 0.000 description 1
• 230000005889 cellular cytotoxicity Effects 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 229940106189 ceramide Drugs 0.000 description 1
• 201000004308 chancroid Diseases 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 229940038705 chlamydia trachomatis Drugs 0.000 description 1
• 150000001841 cholesterols Chemical class 0.000 description 1
• 238000013375 chromatographic separation Methods 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 230000008711 chromosomal rearrangement Effects 0.000 description 1
• 201000003486 coccidioidomycosis Diseases 0.000 description 1
• 201000003740 cowpox Diseases 0.000 description 1
• 125000000753 cycloalkyl group Chemical group 0.000 description 1
• 210000000172 cytosol Anatomy 0.000 description 1
• 238000007405 data analysis Methods 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 208000025729 dengue disease Diseases 0.000 description 1
• 108010017271 denileukin diftitox Proteins 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• 239000005546 dideoxynucleotide Substances 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 230000009266 disease activity Effects 0.000 description 1
• 231100000676 disease causative agent Toxicity 0.000 description 1
• 230000002222 downregulating effect Effects 0.000 description 1
• 230000037437 driver mutation Effects 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 239000003814 drug Substances 0.000 description 1
• 229940056913 eftilagimod alfa Drugs 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 239000003925 fat Substances 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• 244000053095 fungal pathogen Species 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 238000003205 genotyping method Methods 0.000 description 1
• 201000006592 giardiasis Diseases 0.000 description 1
• 108060003196 globin Proteins 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• 229940047650 haemophilus influenzae Drugs 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 230000003862 health status Effects 0.000 description 1
• 229940037467 helicobacter pylori Drugs 0.000 description 1
• 244000000013 helminth Species 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 238000003268 heterogeneous phase assay Methods 0.000 description 1
• 102000047119 human OCA2 Human genes 0.000 description 1
• 230000004727 humoral immunity Effects 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 229960002751 imiquimod Drugs 0.000 description 1
• DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 1
• 230000006058 immune tolerance Effects 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 239000000568 immunological adjuvant Substances 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 239000003999 initiator Substances 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 238000012886 linear function Methods 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 238000007477 logistic regression Methods 0.000 description 1
• 208000001581 lymphogranuloma venereum Diseases 0.000 description 1
• 210000003563 lymphoid tissue Anatomy 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 230000002132 lysosomal effect Effects 0.000 description 1
• 238000010801 machine learning Methods 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 201000004015 melioidosis Diseases 0.000 description 1
• 210000001806 memory b lymphocyte Anatomy 0.000 description 1
• 210000003071 memory t lymphocyte Anatomy 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 229940035032 monophosphoryl lipid a Drugs 0.000 description 1
• 201000007524 mucormycosis Diseases 0.000 description 1
• 230000000869 mutational effect Effects 0.000 description 1
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 230000037434 nonsense mutation Effects 0.000 description 1
• 239000002853 nucleic acid probe Substances 0.000 description 1
• 238000011330 nucleic acid test Methods 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 229940100027 ontak Drugs 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 201000000901 ornithosis Diseases 0.000 description 1
• 208000003154 papilloma Diseases 0.000 description 1
• 230000003071 parasitic effect Effects 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 229940051027 pasteurella multocida Drugs 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 230000009984 peri-natal effect Effects 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 208000011079 pinta disease Diseases 0.000 description 1
• 229920000573 polyethylene Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 244000144977 poultry Species 0.000 description 1
• 235000013594 poultry meat Nutrition 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 230000002028 premature Effects 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 229940007042 proteus vulgaris Drugs 0.000 description 1
• 208000009305 pseudorabies Diseases 0.000 description 1
• 238000012175 pyrosequencing Methods 0.000 description 1
• 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
• 238000010223 real-time analysis Methods 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000003252 repetitive effect Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 208000023504 respiratory system disease Diseases 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 238000004007 reversed phase HPLC Methods 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• 229930182490 saponin Natural products 0.000 description 1
• 150000007949 saponins Chemical class 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 201000004409 schistosomiasis Diseases 0.000 description 1
• 238000007790 scraping Methods 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 238000010187 selection method Methods 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 238000004557 single molecule detection Methods 0.000 description 1
• 230000000391 smoking effect Effects 0.000 description 1
• JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 1
• 230000000392 somatic effect Effects 0.000 description 1
• 230000037436 splice-site mutation Effects 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 150000003432 sterols Chemical class 0.000 description 1
• 235000003702 sterols Nutrition 0.000 description 1
• 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 208000006379 syphilis Diseases 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 229940021747 therapeutic vaccine Drugs 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 241001147422 tick-borne encephalitis virus group Species 0.000 description 1
• 239000003104 tissue culture media Substances 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000000844 transformation Methods 0.000 description 1
• 238000011282 treatment Methods 0.000 description 1
• 208000003982 trichinellosis Diseases 0.000 description 1
• 201000007588 trichinosis Diseases 0.000 description 1
• YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
• 229960004319 trichloroacetic acid Drugs 0.000 description 1
• 239000001226 triphosphate Substances 0.000 description 1
• 235000011178 triphosphate Nutrition 0.000 description 1
• 201000002311 trypanosomiasis Diseases 0.000 description 1
• 230000037455 tumor specific immune response Effects 0.000 description 1
• 206010061393 typhus Diseases 0.000 description 1
• 241000724775 unclassified viruses Species 0.000 description 1
• 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
• 208000007089 vaccinia Diseases 0.000 description 1
• 229940118696 vibrio cholerae Drugs 0.000 description 1
• 239000000277 virosome Substances 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 101150040614 vpx gene Proteins 0.000 description 1
• 201000009482 yaws Diseases 0.000 description 1